SEVERE APLASTIC ANEMIA (SAA)

Clinical trials for SEVERE APLASTIC ANEMIA (SAA) explained in plain language.

Never miss a new study

Get alerted when new SEVERE APLASTIC ANEMIA (SAA) trials appear

Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA (SAA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2 Completed 1 Terminated 1

Experimental drug for rare bone marrow disease shows early promise, but study halted

Disease control Terminated

This study tested an experimental drug called REGN7257 in 17 people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The drug was given to patients whose disease did not get better or came back after standard immune-suppressing …

Matched conditions: SEVERE APLASTIC ANEMIA (SAA)

Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

SEVERE APLASTIC ANEMIA (SAA)

Get alerted when new SEVERE APLASTIC ANEMIA (SAA) trials appear

Experimental drug for rare bone marrow disease shows early promise, but study halted